September 26, 2016 12:39 PM ET


Company Overview of HemoShear Therapeutics, LLC

Key Executives for HemoShear Therapeutics, LLC

NameBoard RelationshipsTitleAge
James C. Powers 38 RelationshipsChairman and Chief Executive Officer64
Brett R. Blackman Ph.D.No RelationshipsCo-Founder and Chief Scientific Officer--
Brian R. Wamhoff Ph.D.8 RelationshipsCo-Founder, Vice President of Research & Development and Director--
Nicole E. Hastings Ph.D.No RelationshipsVice President of Operations--

HemoShear Therapeutics, LLC Board Members*

NameBoard RelationshipsPrimary CompanyAge
James C. Powers 38 RelationshipsHemoShear Therapeutics, LLC64
Brian R. Wamhoff Ph.D. 8 RelationshipsHemoShear Therapeutics, LLC--
W. McIlwaine Thompson Jr. 15 RelationshipsHemoShear Therapeutics, LLC56
Reginald F. Woods 9 RelationshipsDeHayes Consulting Group--
John L. Brooks III, CPA 50 RelationshipsPrism VentureWorks65
View All Board Members

HemoShear Therapeutics, LLC Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Executive Committee Reginald F. Woods9 Relationships1 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
HemoShear Therapeutics, LLC CEO Compensation
Industry Average


GlycoMimetics, Inc. Announces the Intention of Franklin H. Top to Resign as Directors Effective January 1, 2017
September 23, 2016 1:31 PM ET
Symic Bio Appoints Thomas N. Wight to Scientific Advisory Board
September 23, 2016 12:01 PM ET
Momenta Pharmaceuticals Inc. Appoints Corey N. Fishman to its Board of Directors
September 23, 2016 12:00 PM ET
uniQure N.V. Announces Management and Board Changes
September 22, 2016 8:18 PM ET
Ligand Pharmaceuticals Incorporated Announces Change of Principal Accounting Officer
September 22, 2016 8:06 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact HemoShear Therapeutics, LLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at